Cargando…

Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab

BACKGROUND: Muscle-infiltrating urothelial carcinoma of the bladder is the most common genitourinary cancer. Immunotherapeutic agents targeting protein-1 programmed death or protein-1 programmed death ligand are currently considered the standard treatment in patients with either inoperable locally a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palacka, Patrik, Janega, Pavol, Polakova, Hana, Slopovsky, Jan, De Angelis, Valentina, Mego, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295275/ https://www.ncbi.nlm.nih.gov/pubmed/35850756 http://dx.doi.org/10.1186/s12894-022-01064-x

Ejemplares similares

Plasma thiobarbituric acid reactive substances predicts survival in chemotherapy naïve patients with metastatic urothelial carcinoma
por: Slopovsky, Jan, et al.
Publicado: (2020)

Changes in CoQ(10)/Lipids Ratio, Oxidative Stress, and Coenzyme Q(10) during First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma (mUC)
por: Palacka, Patrik, et al.
Publicado: (2022)

A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

Platelet Mitochondrial Bioenergetics Reprogramming in Patients with Urothelial Carcinoma
por: Palacka, Patrik, et al.
Publicado: (2021)

Malignant pericardial effusion complicated by cardiac tamponade under atezolizumab
por: Benjamin, Lardinois, et al.
Publicado: (2021)

Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC)
por: Palacka, Patrik, et al.
Publicado: (2022)

Factors Associated With Choriocarcinoma Syndrome Development in Poor-Risk Patients With Germ Cell Tumors
por: Rejlekova, Katarina, et al.
Publicado: (2022)

Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors
por: Hapakova, Nikola, et al.
Publicado: (2022)

Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report
por: Rkman, Deni, et al.
Publicado: (2019)

Response of the Urothelial Carcinoma Cell Lines to Cisplatin
por: Holíčková, Andrea, et al.
Publicado: (2022)

A Case of Malignant Pericardial Mesothelioma With Constrictive Pericarditis Physiology Misdiagnosed as Pericardial Metastatic Cancer
por: Lee, Man Jong, et al.
Publicado: (2011)

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
por: Aydin, Ahmet Murat, et al.
Publicado: (2017)

Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
por: Liu, Xiaoyan, et al.
Publicado: (2022)

Sudden cardiac death due to primary malignant pericardial mesothelioma: Brief report and literature review
por: Martínez-Girón, Rafael, et al.
Publicado: (2019)

Role of atezolizumab therapy combined with platinum-based chemotherapy in untreated metastatic urothelial carcinoma – The new landscapes (IMvigor130 trial)
por: Misra, Ankit
Publicado: (2021)

De Novo Myasthenia Gravis Induced by Atezolizumab in a Patient with Urothelial Carcinoma
por: Thakolwiboon, Smathorn, et al.
Publicado: (2019)

Disease Control with Prior Platinum-based Chemotherapy Is Prognostic for Survival in Patients with Metastatic Urothelial Cancer Treated with Atezolizumab in Real-world Practice
por: Mencinger, Marina, et al.
Publicado: (2021)

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
por: Jang, H. Josh, et al.
Publicado: (2023)

Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective Study
por: Hur, Joon Young, et al.
Publicado: (2019)

Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis
por: Parisi, Alessandro, et al.
Publicado: (2019)

Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies
por: Sotelo, M., et al.
Publicado: (2020)

The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
por: Sezenöz, Burak, et al.
Publicado: (2023)

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors
por: Chovanec, Michal, et al.
Publicado: (2023)

Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
por: Hoffman-Censits, Jean, et al.
Publicado: (2020)

Management of Malignant Pericardial Effusion
por: Petrofsky, Mary
Publicado: (2014)

Spontaneous secondary pneumothorax with concomitant malignant pericardial effusion in the context of metastatic synovial sarcoma
por: Karapanos, Lewis, et al.
Publicado: (2023)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours
por: Lesko, Peter, et al.
Publicado: (2023)

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report
por: Küronya, Zsófia, et al.
Publicado: (2022)

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
por: Grande, Enrique, et al.
Publicado: (2023)

Pericardial Metastasis Induced Tamponade from Urothelial Carcinoma: A Rare Entity
por: Khan, Rafay, et al.
Publicado: (2016)

Malignant pericardial effusion as a primary manifestation of metastatic colon cancer: a case report
por: Neves, Milena Brachmans Mascarenhas, et al.
Publicado: (2021)

Metastatic urothelial carcinoma()()
por: Gómez-Moyano, Elisabeth, et al.
Publicado: (2021)

FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy
por: Suzman, Daniel L., et al.
Publicado: (2018)

FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy
por: Ning, Yang‐Min, et al.
Publicado: (2017)

Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy
por: Kerioui, M., et al.
Publicado: (2021)

Atezolizumab-Induced Autoimmune Diabetes in a Patient With Metastatic Lung Cancer
por: Sothornwit, Jin, et al.
Publicado: (2019)

Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report
por: Yamaguchi, Yoshitaka, et al.
Publicado: (2020)

Atezolizumab-associated encephalitis in metastatic breast cancer: A case report
por: Chen, Guixian, et al.
Publicado: (2022)

Acute liver failure due to radiographically occult infiltration of urothelial cancer
por: Tosatto, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nvshch8e3p1jt017piruo73mpo